Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).
Publication
, Journal Article
Gattis, WA; O'Connor, CM; Hasselblad, V; Adams, KF; Kobrin, I; Gheorghiade, M
Published in: Am J Cardiol
June 1, 2004
The relation of cardiac troponin-I (cTnI) to clinical outcomes was examined in patients with decompensated heart failure and concomitant acute coronary syndrome enrolled into the Randomized Intravenous TeZosentan 4 (RITZ-4) study. RITZ-4 was a multicenter, randomized, double-blind, placebo-controlled trial of the endothelin receptor antagonist tezosentan in patients admitted with acute heart failure and concomitant acute coronary syndrome. One hundred ninety-two patients were enrolled in this study. Patients with baseline cTnI values were included in this analysis, and the relation between cTnI and the composite clinical primary end point of RITZ-4 was evaluated.
Duke Scholars
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
June 1, 2004
Volume
93
Issue
11
Start / End Page
1436 / A10
Location
United States
Related Subject Headings
- Vasodilator Agents
- Troponin I
- Tetrazoles
- Risk Factors
- Retrospective Studies
- Randomized Controlled Trials as Topic
- Pyridines
- Multicenter Studies as Topic
- Male
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Gattis, W. A., O’Connor, C. M., Hasselblad, V., Adams, K. F., Kobrin, I., & Gheorghiade, M. (2004). Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol, 93(11), 1436-A10. https://doi.org/10.1016/j.amjcard.2004.02.051
Gattis, Wendy A., Christopher M. O’Connor, Vic Hasselblad, Kirkwood F. Adams, Isaac Kobrin, and Mihai Gheorghiade. “Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).” Am J Cardiol 93, no. 11 (June 1, 2004): 1436-A10. https://doi.org/10.1016/j.amjcard.2004.02.051.
Gattis WA, O’Connor CM, Hasselblad V, Adams KF, Kobrin I, Gheorghiade M. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol. 2004 Jun 1;93(11):1436-A10.
Gattis, Wendy A., et al. “Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).” Am J Cardiol, vol. 93, no. 11, June 2004, pp. 1436-A10. Pubmed, doi:10.1016/j.amjcard.2004.02.051.
Gattis WA, O’Connor CM, Hasselblad V, Adams KF, Kobrin I, Gheorghiade M. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol. 2004 Jun 1;93(11):1436-A10.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
June 1, 2004
Volume
93
Issue
11
Start / End Page
1436 / A10
Location
United States
Related Subject Headings
- Vasodilator Agents
- Troponin I
- Tetrazoles
- Risk Factors
- Retrospective Studies
- Randomized Controlled Trials as Topic
- Pyridines
- Multicenter Studies as Topic
- Male
- Humans